CDKN2A and melanoma: Already before the rise of GWAS, deletions of the ANRIL lncRNA gene upstream of the CDKN2A and CDKN2B genes have been associated with increased risk of melanoma and neural system tumor development in several families (see section Amplifications and Deletions).